Bergstrom R - Search Results

1

Duloxetine: clinical pharmacokinetics and drug interactions.

Knadler MP, Lobo E, Chappell J, Bergstrom R. Knadler MP, et al. Among authors: bergstrom r. Clin Pharmacokinet. 2011 May;50(5):281-94. doi: 10.2165/11539240-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21366359 Review.

2

Pharmacokinetics of duloxetine in breast milk and plasma of healthy postpartum women.

Lobo ED, Loghin C, Knadler MP, Quinlan T, Zhang L, Chappell J, Lucas R, Bergstrom RF. Lobo ED, et al. Among authors: bergstrom rf. Clin Pharmacokinet. 2008;47(2):103-9. doi: 10.2165/00003088-200847020-00003. Clin Pharmacokinet. 2008. PMID: 18193916 Clinical Trial.

3

In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine.

Lobo ED, Bergstrom RF, Reddy S, Quinlan T, Chappell J, Hong Q, Ring B, Knadler MP. Lobo ED, et al. Clin Pharmacokinet. 2008;47(3):191-202. doi: 10.2165/00003088-200847030-00005. Clin Pharmacokinet. 2008. PMID: 18307373 Clinical Trial.

4

Oral olanzapine disposition in adolescents with schizophrenia or bipolar I disorder: a population pharmacokinetic model.

Lobo ED, Robertson-Plouch C, Quinlan T, Hong Q, Bergstrom RF. Lobo ED, et al. Paediatr Drugs. 2010 Jun;12(3):201-11. doi: 10.2165/11532580-000000000-00000. Paediatr Drugs. 2010. PMID: 20297865

5

Nizatidine, and H2-receptor antagonist: disposition and safety in the elderly.

Callaghan JT, Rubin A, Knadler MP, Bergstrom RF. Callaghan JT, et al. Among authors: bergstrom rf. J Clin Pharmacol. 1987 Aug;27(8):618-24. doi: 10.1002/j.1552-4604.1987.tb03075.x. J Clin Pharmacol. 1987. PMID: 2888796

6

Secretion of nizatidine into human breast milk after single and multiple doses.

Obermeyer BD, Bergstrom RF, Callaghan JT, Knadler MP, Golichowski A, Rubin A. Obermeyer BD, et al. Among authors: bergstrom rf. Clin Pharmacol Ther. 1990 Jun;47(6):724-30. doi: 10.1038/clpt.1990.100. Clin Pharmacol Ther. 1990. PMID: 1972674

7

Absorption studies of the H2-blocker nizatidine.

Knadler MP, Bergstrom RF, Callaghan JT, Obermeyer BD, Rubin A. Knadler MP, et al. Among authors: bergstrom rf. Clin Pharmacol Ther. 1987 Nov;42(5):514-20. doi: 10.1038/clpt.1987.190. Clin Pharmacol Ther. 1987. PMID: 2890459 Clinical Trial.

8

A pharmacokinetic profile of nizatidine in man.

Callaghan JT, Bergstrom RF, Rubin A, Chernish S, Crabtree R, Knadler MP, Obermeyer B, Offen WW, Schneck DW, Aronoff G, et al. Callaghan JT, et al. Among authors: bergstrom rf. Scand J Gastroenterol Suppl. 1987;136:9-17. doi: 10.3109/00365528709094480. Scand J Gastroenterol Suppl. 1987. PMID: 2892261 Review.

9

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

Callaghan JT, Bergstrom RF, Ptak LR, Beasley CM. Callaghan JT, et al. Among authors: bergstrom rf. Clin Pharmacokinet. 1999 Sep;37(3):177-93. doi: 10.2165/00003088-199937030-00001. Clin Pharmacokinet. 1999. PMID: 10511917 Review.

10

The effect of sertraline on the pharmacokinetics of desipramine and imipramine.

Kurtz DL, Bergstrom RF, Goldberg MJ, Cerimele BJ. Kurtz DL, et al. Among authors: bergstrom rf. Clin Pharmacol Ther. 1997 Aug;62(2):145-56. doi: 10.1016/S0009-9236(97)90062-X. Clin Pharmacol Ther. 1997. PMID: 9284850 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

578 results

Search Page

Filters